Suicidal thoughts end Amgen's blockbuster aspirations for psoriasis drug.
Charlie
C
Schmidt
D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D002986:Clinical Trials as Topic; D003879:Dermatologic Agents / Q000009:adverse effects / Q000627:therapeutic use; D004345:Drug Industry / Q000458:organization & administration*; D057239:Early Termination of Clinical Trials; D006801:Humans; D011565:Psoriasis / Q000188:drug therapy*; D059020:Suicidal Ideation
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D003879:Dermatologic Agents; C571216:brodalumab